Affordable Vaccine platform
March 2014Promoted by scientist- turned entrepreneur, Tergene Biotech has made a mark in a short period of time. The company is envisioned to provide quality human biologics.
Promoted by scientist- turned entrepreneur, Tergene Biotech has made a mark in a short period of time. The company is envisioned to provide quality human biologics.
Dr. M. Kuppusamy receiving the DBT - BIRAC Innovator Award from Dr. G. Padmanaban, Advisor, Department of BioTechnology, Govt. of India and Dr. K. Vijayraghavan, Secretary, DBT.
With funding from BIPP, Tergene initiated a project to develop an indigenous vaccine to tackle pneumonia that kills more children under the age of five than any other disease.